Results 91 to 100 of about 5,123 (202)

Pharmacoeconomic analysis of using the darbepoetin alfa to correct anemia in patients with chronic renal failure who are on hemodialysis or peritoneal dialysis

Качественная клиническая практика, 2018
Goal: to conduct pharmacoeconomic analysis of using the darbepoetin alfa (Aranesp) and other erythropoiesis-stimulating agents for anemia correction in patients on hemodialysis or peritoneal dialysis. Methodology.
I. S. Krysanov, T. S. Fakeeva, O. N. Kotenko   +2 more
doaj  

Protective effects of Tadalafil and darbepoetin against ischemia - reperfusion injury in a rat testicular torsion model

International Brazilian Journal of Urology
Objectives: To evaluate protective effects of darbepoetin and tadalafil against ischemia-reperfusion injury in ipsilateral and contralateral testicle. Materials and Methods: Thirty 3-month-old adult male Wistar-Albino rats were randomly divided into 5 ...
Caglar Yildirim, Ozgur H. Yuksel, Ahmet Urkmez, Aytac Sahin, Adnan Somay, Ayhan Verit   +5 more
doaj   +1 more source

Darbepoetin versus Epoetin Alfa for the Correction of Anemia in Cancer Patients Receiving Radiotherapy or Chemoradiotherapy Treatment

Clinical Medicine Insights: Oncology, 2008
Introduction Anemia is the most frequent hematological disturbance in cancer patients, with prevalence between 30% and 90%, depending on the type of tumor, the antitumor treatment, and other factors (infection, malnutrition, bleeding, tumor infiltration ...
Pilar M Samper Ots, Concepción López Carrizosa, Aurora Rodríguez Pérez, Juan De Dios Saez Garrido, José M Delgado Pérez   +4 more
doaj   +1 more source

Erythropoiesis stimulating agents approaches to modulate activity

Biologics: Targets & Therapy, 2013
Angus M Sinclair Amgen Inc, Thousand Oaks, CA, USA Abstract: Recombinant human erythropoietin (rHuEPO), such as the approved agents epoetin alfa and epoetin beta, has been used successfully for over 20 years to treat anemia in millions of patients ...
Sinclair AM
doaj  

The QUEST initiative anemia study in ESRD: rationale and study protocol [PDF]

, 2007
No ...
Del Vecchio, Lucia, Deska-Slizien, Alicja, Jager, Kitty J., Locatelli, Francesco, Martins Prata, Mateus, Mauri, Joan M., Metsarinne, Kaj, Mircescu, Gabriel, Siamopoulos, Kostas C., Stel, Vianda S., Van Biesen, Wim, Wauters, Jean Pierre, Will, Eric, Zoccali, Carmine   +13 more
core  

Darbepoetin Use for the Treatment of Anemia in Hemodialysis Patients in Saudi Arabia

Saudi Journal of Kidney Diseases and Transplantation, 2006
Erythropoietin replacing proteins have improved patient outcomes and quality of life. Darbepoetin has a 3-fold longer half-life than recombinant human erythropoietin (rHuEPO).
Shaheen Faissal, Akeel Nabila, Alfi Adnan, Harbi Ali, Tarif Nauman, Souqiyyeh Mohammad   +5 more
doaj  

Redefining anaemia management in CKD: comparative insights on desidustat, roxadustat, and molidustat as oral HIF-PH inhibitors

Clinical Medicine
Introduction: Anaemia affects over 50% of advanced chronic kidney disease (CKD) patients, increasing cardiovascular mortality. Traditional erythropoiesis-stimulating agents (ESAs) require injections and carry risks, such as hypertension and ...
Kaandeeban Mohanraj, Cheryl Singla, Vidhya Mohanraj, Vishnuvardan Venkatramanan   +3 more
doaj   +1 more source

Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.

PLoS ONE, 2016
Anemia management, based on erythropoiesis stimulating agents (ESA) and iron supplementation, has become an increasingly challenging problem in hemodialysis patients.
Carlo Barbieri, Elena Bolzoni, Flavio Mari, Isabella Cattinelli, Francesco Bellocchio, José D Martin, Claudia Amato, Andrea Stopper, Emanuele Gatti, Iain C Macdougall, Stefano Stuard, Bernard Canaud   +11 more
doaj   +1 more source

Estudio retrospectivo de la influencia de la respuesta al tratamiento quimioterápico de primera línea en pacientes con cáncer no microcítico de pulmón sobre la respuesta a la administración de factores estimulantes de la eritropoyesis en la anemia inducida por quimioterapia [PDF]

, 2012
S'analitza de manera retrospectiva la relació entre la resposta a la quimioteràpia i la milloria de l'anèmia induïda per la quimioteràpia amb factors estimulants de la eritropoesi en 57 pacients amb carcinoma no microcític de pulmó avançat que ...
Blasco Mollá, Sara, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina   +2 more
core  

Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure [PDF]

, 2016
Aims Although previous reports suggest that an elevated endogenous erythropoietin (EPO) level is associated with worse clinical outcomes in chronic heart failure (HF) patients, the prognostic implication of EPO in patients with acute decompensated HF ...
Anand, Anker, Asaumi, Beguin, Belonje, Belonje, Belonje, Breunig, Cazzola, Diskin, Ezekowitz, Feldschuh, George, Ghali, Grote Beverborg, Levy, Lipsic, Massie, McKee, Meer, Meer, Meer, Silverberg, Smilde, Swedberg, Takei, Teerlink, Westenbrink   +27 more
core   +1 more source